Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KXL System with VibeX for Keratoconus
NCT01344187Phase 3Completed
- Sponsor
- Glaukos Corporation
- Start
- Jul 2012
- Primary completion
- Jun 2015
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of riboflavin in keratoconus, sponsored by Glaukos Corporation. Started Jul 2012; status: completed.
02
Drugs
riboflavin
03
Conditions
keratoconus
Beyond the preview
Go deeper on NCT01344187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01344187.